EverSource Wealth Advisors’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRS
EverSource Wealth Advisors's ATRS Position: Q2 2022 in Review
EverSource Wealth Advisors sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 1,352 shares — an estimated $6K sold.
EverSource Wealth Advisors first reported a position in ATRS in Q1 2022 and held it in 1 quarter. The position peaked at $6K in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- EverSource Wealth Advisors reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- EverSource Wealth Advisors sold 1,352 Antares Pharma, Inc. shares in Q2 2022, an estimated $6K.
- EverSource Wealth Advisors first reported a position in Antares Pharma, Inc. in Q1 2022 and held it in 1 quarter.
- EverSource Wealth Advisors's Antares Pharma, Inc. position peaked at $6K in Q1 2022.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on EverSource Wealth Advisors's 13F filing for Q2 2022, filed 1 Aug 2022.